Press Releases

More than 2,000 Students from 144 Schools Participated in The Tech's Premier Engineering Design Program

SAN JOSE, Calif., April 29, 2024 /PRNewswire/ -- The Tech, the world-renowned science, technology, and education center in the heart of Silicon Valley, announces the results of the Final Showcase of 37th Annual Tech Challenge, which took place on April 27-28 in downtown San Jose. Presented by Amazon, The Tech Challenge drew thousands of students in grades 4-12 to... (continue reading...)

Toronto, Ontario--(Newsfile Corp. - April 29, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") today reported unaudited financial results for the first quarter ended February 29, 2024. The Company is pleased to present a general operational update regarding its assets and investments. All figures in this press release are in Canadian dollars, unless otherwise indicated.

Unaudited Q1 FY 2024 Results

• For the... (continue reading...)

TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- Nexus Industrial REIT (“Nexus” or the "REIT") (TSX: NXR.UN) announced today that it intends to release its financial results for the quarter ended March 31, 2024, before the opening of the TSX on Wednesday May 15, 2024.

Management of the REIT will host a conference call at 10:00 AM Eastern Standard Time on Wednesday May 15, 2024, to review the financial results and operations.

To participate in the conference call,... (continue reading...)

- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination Studies

- SITC 2023 Presentation of the Phase 1 Topline Clinical and Mechanism Data of BeyondSpring’s Lead Asset Plinabulin in Combination with PD-1 Inhibitor and Radiation in a Number of Immune Checkpoint Inhibitor Failed Cancers (Disease Control Rate 50%), Collaboration with MD Anderson

- SEED Therapeutics (“SEED”), a BeyondSpring... (continue reading...)

FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”) on April 29, 2024. The annual report on Form 20-F, which contains the... (continue reading...)